Terns Pharmaceuticals Dividends
| TERN Stock | USD 4.66 0.14 3.10% |
As of the 7th of February 2025, Dividend Paid And Capex Coverage Ratio is likely to grow to -1,416. Terns Pharmaceuticals' past performance could be the main factor of why investors trade Terns Pharmaceuticals stock today. Investors should clearly understand every aspect of the Terns Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Terns Pharmaceuticals' dividend schedule and payout information. Terns Pharmaceuticals dividends can also provide a clue to the current valuation of Terns Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | -1.5 K | -1.4 K |
Terns |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Terns Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.